This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Gmi-Gregor Mendel-Institut Fuer Molekulare Pflanzenbiologie Gmbh, Harvard College, Massachusetts Institute of Technology. Active years: 2025-2026.
Company Filing History:
1 out of 2 
1 out of 3,069 
1 out of 8,573 
Years Active: 2025-2026
Title: Max Kellner: Innovator in Molecular Biology
Introduction
Max Kellner is a prominent inventor based in Cambridge, MA (US), known for his contributions to molecular biology. He holds 2 patents that focus on advanced methods for detecting nucleic acid sequences. His work has significant implications for genetic research and diagnostics.
Latest Patents
Kellner's latest patents include innovative technologies such as CRISPR/Cas and transposase-based amplification compositions, systems, and methods. These patents provide methods for detecting target nucleic acid sequences by utilizing a transposon complex. The process involves inserting T7 RNA promoters into oligonucleotides and amplifying the target nucleic acid sequence. Additionally, he has developed a novel method called nanoPARE, which allows for the generation of multiple sequencing libraries from a single full-length cDNA library, specifically focusing on RNA 5' end sequencing.
Career Highlights
Throughout his career, Max Kellner has worked with esteemed institutions such as Harvard College and the Gregor Mendel Institute for Molecular Plant Biology. His research has contributed to the advancement of molecular techniques that enhance our understanding of genetic material.
Collaborations
Kellner has collaborated with notable colleagues, including Michael Schön and Omar Abudayyeh, further enriching his research endeavors and expanding the impact of his work.
Conclusion
Max Kellner's innovative contributions to molecular biology and his patents reflect his commitment to advancing genetic research. His work continues to influence the field and pave the way for future discoveries.